Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE Registry

20255 citationsJournal Articlehybrid Open Access

Authors

Liana Barenbrug · Radboud University Nijmegen

Renate G. van der Molen · Radboud University Nijmegen

Jake S.F. Maurits · Radboud University Nijmegen

Marieke M.B. Seyger · Radboud University Nijmegen

Marisol E. Otero · Radboud University Nijmegen

Antoni H. Gostynski · University Medical Center

Femke M. Homan

Abstract

Biologics, including IL17i and IL23i, showed lower drug survival rates for females. This could be linked to the sex-differences we found regarding AEs and treatment satisfaction with biologics<b>.</b>

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Asthma and respiratory diseases Dermatology and Skin Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Psoriasis and Psoriatic Arthritis

Volume 10, Issue 3, pp. 91-100

DOI: 10.1177/24755303251327926

Field-Weighted Citation Impact: 3.89